4. Puxty K, McLoone P, Quasim T, Sloan B, Kinsella J, Morrison DS. Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA oncol 2015;1:1078–1085.
6. Ediboğlu Ö, Kirakli SC, MOÇİN ÖY, Güngör G, Anar C, Cimen P, et al. Predictors of mortality in cancer patients who need intensive care unit support: a two center cohort study. Turk J Med Sci 2018;48:744–749.
9. Aygencel G, Turkoglu M, Sucak GT, Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care 2014;29:618–626.
19. Liu G, Lv H, An Y, Wei X, Yi H, Yi H. Early actate levelsfor prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Clin Exp Med 2017;10:37–47.
20. Juneja D, Singh O, Dang R. Admission hyperlactatemia: causes, incidence, and impact on outcome of patients admitted in a general medical intensive care unit. J Crit Care 2011;26:316–320.
23. Patout M, Salaün M, Brunel V, Bota S, Cauliez B, Thiberville L. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clin Biochem 2014;47:263–267.
29. Zain OM, Elsayed MY, Abdelkhalig SM, Abdelaziz M, Ibrahim SY, Bashir T, et al. Bloodstream infection in cancer patients; susceptibility profiles of the isolated pathogens, at Khartoum Oncology Hospital, Sudan. Afr Health Sci 2022;4:70–76.